Cost-effectiveness of the National Diabetes Prevention Program: A Real-world, 2-Year Prospective Study.

Although the differences in direct medical costs and in QALYs between enrollees and nonenrollees did not reach statistical significance, it should be remembered that the estimates of incremental costs and benefits are surrounded by substantial uncertainty.

also in 111,027 other papers